#USA #New York #Trulieve #Cannabis #NYSE

Trulieve's Historic Moment at the NYSE

On August 18, 2026, Trulieve Cannabis Corp. made history as it rang the closing bell at the New York Stock Exchange (NYSE), becoming the first U.S. cannabis company to be publicly traded on one of the country's major stock exchanges. This milestone marks not just an achievement for the company, but it also signifies the evolving landscape of the cannabis industry in the United States, which is gaining increased recognition in the financial markets.

The event took place at 4:00 PM ET and was attended by Trulieve's Founder and CEO, Kim Rivers, alongside the Board of Directors and executive leaders. In a heartfelt statement, Rivers expressed gratitude toward the team and all contributors to the company's success, emphasizing the importance of the NYSE listing as a reflection of years of hard work, operational excellence, and a commitment to delivering long-term value for shareholders.

A Look Inside Trulieve

Trulieve has established itself as the largest medical cannabis operator in the U.S. with a network of 207 dispensaries and over 5,000 employees. Its impressive operational footprint includes a robust cultivation and production capacity, totalling 3.5 million square feet across various states, including Florida, Georgia, Pennsylvania, and West Virginia. The company has set the gold standard in the burgeoning medical cannabis market, which is experiencing significant growth as more states adopt favorable regulations.

Recent Developments

A pivotal development leading up to this event was the federal rescheduling of medical marijuana to Schedule III in April 2026. This change allowed all Trulieve dispensaries to register with the U.S. Drug Enforcement Administration (DEA). Inspections in key states like Florida, Pennsylvania, and West Virginia were successfully completed, enabling Trulieve to operate efficiently and expand its reach.

In Georgia, the medical marijuana program witnessed an uptick in patient enrollment due to the recent SB 220 legislation, allowing Trulieve to introduce its Modern Flower and Roll One branded vaping products in dispensaries and pharmacies.

The company is also making strides in Texas, where it has completed initial production capacity preparations and is set to serve patients through the Texas Compassionate Use Program (TCUP) once final licensing is granted.

A Strong Financial Backbone

Financially, Trulieve has demonstrated resilience and robustness. In the first half of 2026, the company generated an impressive $109 million in cash flow from operations. Ending the second quarter with $325 million in cash underlines Trulieve's strong market position and readiness to capitalize on future opportunities.

Celebrating a New Chapter

The closing bell ceremony not only honored Trulieve’s successes but also signified a new chapter for the company and the cannabis sector at large. A video of the bell-ringing, showcasing this historic event, will be made available on the NYSE's website for public viewing.

As Trulieve forges ahead, it remains focused on expanding access to high-quality cannabis products and aims for accelerated growth through its strategic operational hubs. More information about Trulieve and its innovative offerings can be found at Trulieve.com.

In summary, the ringing of the closing bell at the NYSE heralds an important moment not only for Trulieve but for the entire cannabis industry, signaling progress and paving the way for greater acceptance and integration into mainstream commerce.